Literature DB >> 10415804

CMT-8/clodronate combination therapy synergistically inhibits alveolar bone loss in LPS-induced periodontitis.

A Llavaneras1, L M Golub, B R Rifkin, P Heikkilä, T Sorsa, O Teronen, T Salo, Y Liu, M E Ryan, N S Ramamurthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10415804     DOI： 10.1111/j.1749-6632.1999.tb07758.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  3 in total

1.  Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines.

Authors:  M Tolomeo; S Grimaudo; S Milano; M La Rosa; V Ferlazzo; G Di Bella; C Barbera; D Simoni; P D'Agostino; E Cillari
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis.

Authors:  Jill E Rogers; Fei Li; Derek D Coatney; Carlos Rossa; Paul Bronson; Jaclynn M Krieder; William V Giannobile; Keith L Kirkwood
Journal:  J Periodontol       Date:  2007-03       Impact factor: 6.993

3.  Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticules.

Authors:  Marco Antonio Botelho; Jose Galberto Martins; Ronaldo Sousa Ruela; Dinalva Brito Queiroz; Wagner Sousa Ruela
Journal:  J Appl Oral Sci       Date:  2010 Jul-Aug       Impact factor: 2.698
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.